You are using an older browser version. Please use a supported version for the best MSN experience.

ETFs in Focus on AbbVie Allergan Deal

The news has put the spotlight on a number of healthcare ETFs, especially biotech and pharma, which could be the best ways for investors to tap the opportunity arising from the ABBV-AGN deal.
image beaconimage beaconimage beacon